| Peter B Laplace, MD | |
|
426 E Freemason St, Norfolk, VA 23510 | |
| (757) 623-6072 | |
| (757) 623-9748 |
| Full Name | Peter B Laplace |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 426 E Freemason St, Norfolk, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003884941 | NPI | - | NPPES |
| 005870879 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0101231082 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Homecare Services | Chesapeake, VA | Home health agency |
| Sentara Leigh Hospital | Norfolk, VA | Hospital |
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Bon Secours Maryview Medical Center | Portsmouth, VA | Hospital |
| Sentara Obici Hospital | Suffolk, VA | Hospital |
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associates In Primary Care Pc | 2365473006 | 3 |
| Ivyrehab Sept, Llc | 7911990908 | 1137 |
News Archive
Microscopes provide valuable insights in the structure and dynamics of cells, in particular when the latter remain in their natural environment. However, this is very difficult especially for higher organisms. Researchers of Karlsruhe Institute of Technology (KIT), the Max Planck Institute for Polymer Research, Mainz, and the American National Institutes of Health (NIH) have now developed a new method to visualize cell structures of an eighth of a micrometer in size in living fish larvae.
Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based COVID-19 vaccine mRNA-1273 (Moderna). The trial findings reveal that the fractional dose regimen of the Moderna vaccine is well tolerated and safe and is capable of inducing robust antibody responses in vaccine recipients. The study is currently available on the medRxiv* preprint server.
A new study discusses the development of dedicated reagents against the SARS-CoV-2 spike protein through the use of an automated CLEIA system.
Bacterin International Holdings, Inc. is pleased to announce the launch of OsteoSTX, a new novel allograft for orthopedic procedures. Utilizing Bacterin's proprietary demineralization technology, OsteoSTX are flexible cortical DBM matchsticks designed for multli-level and deformity spinal applications.
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal, and metabolic diseases, today presented Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo.
› Verified 5 days ago
| Entity Name | Associates In Primary Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982796090 PECOS PAC ID: 2365473006 Enrollment ID: O20050823000554 |
News Archive
Microscopes provide valuable insights in the structure and dynamics of cells, in particular when the latter remain in their natural environment. However, this is very difficult especially for higher organisms. Researchers of Karlsruhe Institute of Technology (KIT), the Max Planck Institute for Polymer Research, Mainz, and the American National Institutes of Health (NIH) have now developed a new method to visualize cell structures of an eighth of a micrometer in size in living fish larvae.
Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based COVID-19 vaccine mRNA-1273 (Moderna). The trial findings reveal that the fractional dose regimen of the Moderna vaccine is well tolerated and safe and is capable of inducing robust antibody responses in vaccine recipients. The study is currently available on the medRxiv* preprint server.
A new study discusses the development of dedicated reagents against the SARS-CoV-2 spike protein through the use of an automated CLEIA system.
Bacterin International Holdings, Inc. is pleased to announce the launch of OsteoSTX, a new novel allograft for orthopedic procedures. Utilizing Bacterin's proprietary demineralization technology, OsteoSTX are flexible cortical DBM matchsticks designed for multli-level and deformity spinal applications.
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal, and metabolic diseases, today presented Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter B Laplace, MD 426 E Freemason St, Norfolk, VA 23510 Ph: (757) 623-6072 | Peter B Laplace, MD 426 E Freemason St, Norfolk, VA 23510 Ph: (757) 623-6072 |
News Archive
Microscopes provide valuable insights in the structure and dynamics of cells, in particular when the latter remain in their natural environment. However, this is very difficult especially for higher organisms. Researchers of Karlsruhe Institute of Technology (KIT), the Max Planck Institute for Polymer Research, Mainz, and the American National Institutes of Health (NIH) have now developed a new method to visualize cell structures of an eighth of a micrometer in size in living fish larvae.
Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based COVID-19 vaccine mRNA-1273 (Moderna). The trial findings reveal that the fractional dose regimen of the Moderna vaccine is well tolerated and safe and is capable of inducing robust antibody responses in vaccine recipients. The study is currently available on the medRxiv* preprint server.
A new study discusses the development of dedicated reagents against the SARS-CoV-2 spike protein through the use of an automated CLEIA system.
Bacterin International Holdings, Inc. is pleased to announce the launch of OsteoSTX, a new novel allograft for orthopedic procedures. Utilizing Bacterin's proprietary demineralization technology, OsteoSTX are flexible cortical DBM matchsticks designed for multli-level and deformity spinal applications.
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal, and metabolic diseases, today presented Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo.
› Verified 5 days ago
Ranjana Neelanjana Mitra, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 830 Kempsville Rd Fl 1, Norfolk, VA 23502 Phone: 757-261-8070 | |
Arunava Paul, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 830 Kempsville Rd, Norfolk, VA 23502 Phone: 757-967-8622 Fax: 757-686-0541 | |
Abbas Asgher Ali, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr, Ste B, Norfolk, VA 23507 Phone: 757-388-3198 Fax: 757-388-4242 | |
Dr. Dace Auzins, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6316 Richmond Cres, Norfolk, VA 23508 Phone: 757-423-8560 | |
Dr. John S Carrick, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 Kempsville Rd, 1st Fl, Norfolk, VA 23502 Phone: 757-261-5283 Fax: 757-261-5849 | |
Dr. Rajden E Kutelia, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr Fl 5, Norfolk, VA 23507 Phone: 757-388-3198 Fax: 757-388-4242 |